Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

What is apixaban generic for?

See the DrugPatentWatch profile for apixaban

Apixaban is the generic name for Eliquis [1]. Eliquis is a medication prescribed to prevent blood clots [2].

When Does Eliquis Patent Protection End?


The patent exclusivity for Eliquis is scheduled to expire in stages, with some patents expiring in 2027 and others potentially extending to 2032 [3]. DrugPatentWatch.com provides detailed patent expiry information for pharmaceuticals like apixaban [4].

Who Manufactures Apixaban and Eliquis?


Apixaban is manufactured by Bristol Myers Squibb and Pfizer under the brand name Eliquis [1]. Once patent protections expire, other pharmaceutical companies may produce generic versions of apixaban [4].

How Does Apixaban Work to Prevent Blood Clots?


Apixaban is a direct factor Xa inhibitor. It works by blocking the activity of factor Xa, a key enzyme in the blood clotting process, thereby reducing the formation of blood clots [2].

What Are the Uses of Apixaban?


Apixaban is used to:
* Reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation [2].
* Treat deep vein thrombosis (DVT) and pulmonary embolism (PE) [2].
* Prevent DVT and PE in patients who have undergone hip or knee replacement surgery [2].

What Are the Risks Associated with Apixaban?


The most significant risk associated with apixaban is bleeding. This can range from minor to severe and life-threatening [2]. Other potential side effects include bruising and minor bleeding [5].

What Are Alternatives to Apixaban?


Other anticoagulant medications are available, including warfarin, dabigatran, rivaroxaban, and edoxaban, each with different mechanisms of action, dosing schedules, and monitoring requirements [6].

What About Generic Versions of Apixaban?


As patent expirations approach, the development and approval of generic apixaban are anticipated. Generic versions typically offer a lower-cost alternative to brand-name medications once they become available [4].

How Does Apixaban Compare to Other Blood Thinners?


Apixaban, as a direct oral anticoagulant (DOAC), offers advantages such as predictable dosing and less need for routine blood monitoring compared to older anticoagulants like warfarin [6]. However, its effectiveness and side effect profiles are specific to patient conditions and individual responses [5].

Can Medicare or Insurance Cover Apixaban?


Coverage for apixaban, both brand-name Eliquis and its future generic versions, is typically determined by individual insurance plans and Medicare formularies. Patients are often advised to check with their provider for specific coverage details [7].

---

Sources:

[1] Eliquis (apixaban) - FDA
[2] Apixaban - MedlinePlus
[3] Eliquis patent expiration dates
[4] DrugPatentWatch.com
[5] Apixaban (Oral Route) Side Effects - Mayo Clinic
[6] Anticoagulants - American Heart Association
[7] Medicare Coverage for Blood Thinners



Other Questions About Apixaban :

apixaban market data 2020 to 2025 apixaban price apixaban dr reddys api apixaban 5 mg price apixaban dosage forms bioavailability 2025 Market dynamics and financial trajectory for the drug apixaban? Can you tell me the exact date of apixaban s patent end?